Protection of Renal Function with RTA405 in Rats with Diabetic Chronic Kidney Disease

Project Details

StatusFinished
Effective start/end date1/04/12 → 31/03/13

Funding

  • Reata Pharmaceuticals, Inc.: $109,039.50
View all
View less

Keywords

  • Diabetes, Obesity, & Metabolic Syndrome, Kidney Research